NAD+, MOTS-c, Sermorelin, CJC-1295, Ipamorelin, and other peptides are often used in longevity-focused protocols, although many still lack strong long-term human data and should be used only with medical supervision and realistic expectations
In the study by Romero-Gomez et al., 53% of patients with cirrhosis had covert encephalopathy, and 84% of patients who developed apparent encephalopathy during follow-up had covert encephalopathy initially
Hormonal evaluation: if a woman is in perimenopause or menopause, the question of whether she needs hormone therapy is addressed first or alongside the peptide decision
That's exactly why we built this bundle
The information provided below focuses on medications, clinical data, and healthcare system factors relevant to the USA